Back

Defining high risk in the cardiovascular-kidney-metabolic syndrome and associated cardiovascular disease outcomes

30 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Metabolic syndrome and heart disease (1) Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Nilay Shah

Northwestern University Feinberg School of Medicine, Chicago (United States of America)

5 More presentations in this session

Presentation thumbnail
High-Intensity interval training improves global longitudinal strain in patients with metabolic syndrome and high risk of heart failure
Doctor E. Garcia Camacho (Toledo, ES)
Abstract Slides Video
Presentation thumbnail
Genetic predisposition of metabolic syndrome independent of weight in premature atherosclerosis
Doctor S. Singh (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
The triglyceride-glucose index is a predictor for cardiovascular events and all-cause mortality in young and middle-aged patients with metabolic syndrome
Doctor W. Chen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome
Associate Professor H. Kim (Guri, KR)
Abstract Slides Video
Presentation thumbnail
A new natural product derived from cyclosorus terminans provides cardiometabolic protection against obese-induced cardiac dysfunction in rats via suppressing mitochondrial dysfunctions and apoptosis
Doctor C. Maneechote (Chiang Mai, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic syndrome and heart disease (1)

The Event

Event poster

ESC Congress 2024

30 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: insights from two real-world prospective registries across europe and east asia
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome in korean: a nationwide stage-specific epidemiology and risk of major adverse cardiovascular events
thumbnail
Congress Presentation
Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources